• Solid Biosciences Inc (SLDB)

    $8.80 | $-0.11 (-1.25%)

  • Dividend Yield

    0.00%

  • SSR Rating

    27

Get Free Stock or Options Report on SLDB

Get Free Report

Solid Biosciences Inc is a life science company. It is engaged in manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. Its lead product candidate, the SGT-001, is a gene transfer under development to restore functional dystrophin protein expression in patients' muscles. The company's pipeline products are the SB-001 and solid suit. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

  • Last Price:
    $8.80
  • Previous Close:
    $8.91
  • Change:
    $-0.11 (-1.23%)
  • Open:
    $8.95
  • Volume:
    424,990
  • Average Volume (100 Day):
    784,208
  • Market Capitalization:
    $311.7 M
  • Day's Range:
    $8.50 - $8.95
  • Dividend Yield:
    0.00%
  • 52-week Range:
    $55 - $5.97
  • P-E:
    0.00
  • EPS:
    $-2.25
  • Earnings Date:
    5/9/19
  • Ex Dividend Date:
    N/A
  • Sector:
    Healthcare
  • Industry:
    Drug Manufacturers - Specialty & Generic
  • Analyst Average Recommendation:
    ■Hold